Expression of GLP-1 receptor and CD26 in human thyroid C-cells: The association of thyroid C-cell tumorigenesis with incretin-based medicine

Recent reports have demonstrated that long-term and high dosage treatments with incretin-based medicine, such as hormone glucagon-like peptide-1 (GLP-1) may induce thyroid C-cell pathological changes in rodents, rather than in humans. Doubts regarding the tumorigenic potential of GLP-1 analogues in...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Yuejia, Zhou, Min, Cao, Yang, Qi, Jiping, Geng, Jingshu, Liu, Xiaomin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403711/
https://www.ncbi.nlm.nih.gov/pubmed/28454451
http://dx.doi.org/10.3892/ol.2017.5752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403711/
https://www.ncbi.nlm.nih.gov/pubmed/28454451
http://dx.doi.org/10.3892/ol.2017.5752

Ejemplares similares